Browse Category

NYSE:VTI News 21 January 2026

Vanguard’s VTI ETF rebounds after Trump’s Greenland tariff threat rattles U.S. stocks

Vanguard’s VTI ETF rebounds after Trump’s Greenland tariff threat rattles U.S. stocks

NEW YORK, Jan 21, 2026, 10:44 EST Vanguard Total Stock Market ETF (VTI) climbed 0.85% to $337.97 in early trading Wednesday, rebounding after Tuesday’s steep tariff-fueled drop in U.S. shares. Other broad-market ETFs followed suit, with SPDR S&P 500 ETF Trust (SPY) gaining 0.7%, Vanguard S&P 500 ETF (VOO) rising 0.8%, and iShares Core S&P Total U.S. Stock Market ETF…

Stock Market Today

  • Delcath Systems Grants Equity Awards to New Hires Under Nasdaq Rule
    January 21, 2026, 4:41 PM EST. Delcath Systems, Inc. (Nasdaq: DCTH), a firm specializing in liver cancer treatments, announced on January 21, 2026, inducement grants totaling 36,250 Restricted Stock Units (RSUs) to four employees hired late 2025. These RSUs vest over three years and comply with Nasdaq Listing Rule 5635(c)(4). The awards stem from Delcath's 2023 Inducement Plan, tying compensation to ongoing employment. Delcath's proprietary HEPZATO KIT, FDA-approved in the U.S., delivers high-dose chemotherapy directly to the liver, minimizing systemic exposure. The company's focus on metastatic uveal melanoma addresses a critical niche in oncology, enhancing its market profile. The stock-based incentives reflect strategic talent acquisition efforts amid evolving therapeutic advancements in interventional oncology.
Go toTop